Abstract

Drug-drug interaction (DDI) is a change in the effect of a drug when patient takes another drug. Characterizing DDIs is extremely important to avoid potential adverse drug reactions. We represent DDIs as a complex network in which nodes refer to drugs and links refer to their potential interactions. Recently, the problem of link prediction has attracted much consideration in scientific community. We represent the process of link prediction as a binary classification task on networks of potential DDIs. We use link prediction techniques for predicting unknown interactions between drugs in five arbitrary chosen large-scale DDI databases, namely DrugBank, KEGG, NDF-RT, SemMedDB, and Twosides. We estimated the performance of link prediction using a series of experiments on DDI networks. We performed link prediction using unsupervised and supervised approach including classification tree, k-nearest neighbors, support vector machine, random forest, and gradient boosting machine classifiers based on topological and semantic similarity features. Supervised approach clearly outperforms unsupervised approach. The Twosides network gained the best prediction performance regarding the area under the precision-recall curve (0.93 for both random forests and gradient boosting machine). The applied methodology can be used as a tool to help researchers to identify potential DDIs. The supervised link prediction approach proved to be promising for potential DDIs prediction and may facilitate the identification of potential DDIs in clinical research.

Highlights

  • Combined use of multiple drugs at the same time is common in modern pharmacotherapy [1], in older population who has required continuous treatment for one or more chronic diseases [2]

  • To better understand the performance of classifiers, we evaluated the significance of their differences in area under the precision-recall curve (AUPR)

  • We evaluate an approach to potential Drug-drug interaction (DDI) prediction using link prediction methodology

Read more

Summary

Introduction

Combined use of multiple drugs at the same time (i.e., polypharmacy) is common in modern pharmacotherapy [1], in older population who has required continuous treatment for one or more chronic diseases [2]. Empirical evidence reported that the percentage of the U.S population taking three or more drugs increased for 12% in years 1988–1994 to 21% in years 2007–2010 [3]. In such settings drugs may interact; they are not independent from one another. Link prediction for drug-drug interaction mining pharmacologic effect of another drug when both are administered together [4, 5]. Identifying DDIs is a critical process in drug industry and clinical patient care, especially in drug administration [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call